Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.

Whitwell JL, Jack CR Jr, Parisi JE, Gunter JL, Weigand SD, Boeve BF, Ahlskog JE, Petersen RC, Dickson DW, Josephs KA.

Eur J Neurol. 2013 Oct;20(10):1417-22. doi: 10.1111/ene.12212. Epub 2013 Jun 7.

2.

Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.

Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C.

Acta Neurol Scand. 2007 Jul;116(1):37-42.

PMID:
17587253
3.

The pimple sign of progressive supranuclear palsy syndrome.

Botha H, Whitwell JL, Madhaven A, Senjem ML, Lowe V, Josephs KA.

Parkinsonism Relat Disord. 2014 Feb;20(2):180-5. doi: 10.1016/j.parkreldis.2013.10.023. Epub 2013 Nov 4.

PMID:
24252300
4.

Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.

Santos-Santos MA, Mandelli ML, Binney RJ, Ogar J, Wilson SM, Henry ML, Hubbard HI, Meese M, Attygalle S, Rosenberg L, Pakvasa M, Trojanowski JQ, Grinberg LT, Rosen H, Boxer AL, Miller BL, Seeley WW, Gorno-Tempini ML.

JAMA Neurol. 2016 Jun 1;73(6):733-42. doi: 10.1001/jamaneurol.2016.0412.

5.

A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.

Borroni B, Malinverno M, Gardoni F, Grassi M, Parnetti L, Agosti C, Alberici A, Premi E, Bonuccelli U, Gasparotti R, Calabresi P, Di Luca M, Padovani A.

J Alzheimers Dis. 2010;22(1):195-203. doi: 10.3233/JAD-2010-100333.

PMID:
20847421
6.

Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.

Sakurai K, Tokumaru AM, Shimoji K, Murayama S, Kanemaru K, Morimoto S, Aiba I, Nakagawa M, Ozawa Y, Shimohira M, Matsukawa N, Hashizume Y, Shibamoto Y.

Neuroradiology. 2017 May;59(5):431-443. doi: 10.1007/s00234-017-1812-4. Epub 2017 Apr 6. Review.

PMID:
28386688
7.

Voxel-based morphometry in autopsy proven PSP and CBD.

Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Jack CR Jr.

Neurobiol Aging. 2008 Feb;29(2):280-9. Epub 2006 Nov 13.

8.

New and reliable MRI diagnosis for progressive supranuclear palsy.

Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S.

Neurology. 2005 Jun 28;64(12):2050-5.

PMID:
15985570
9.

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, Savoiardo M, Girotti F.

Neurology. 1999 Aug 11;53(3):502-7.

PMID:
10449111
10.

Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.

Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB.

Neuroimage. 2004 Feb;21(2):714-24.

PMID:
14980574
11.

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ.

Arch Neurol. 2006 Jan;63(1):81-6.

PMID:
16401739
12.

The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.

Sakurai K, Imabayashi E, Tokumaru AM, Hasebe S, Murayama S, Morimoto S, Kanemaru K, Takao M, Shibamoto Y, Matsukawa N.

Neuroimage Clin. 2014 Feb 27;7:605-10. doi: 10.1016/j.nicl.2014.02.009. eCollection 2015.

13.

Imaging-pathologic correlation in corticobasal degeneration.

Tokumaru AM, Saito Y, Murayama S, Kazutomi K, Sakiyama Y, Toyoda M, Yamakawa M, Terada H.

AJNR Am J Neuroradiol. 2009 Nov;30(10):1884-92. doi: 10.3174/ajnr.A1721. Epub 2009 Oct 15.

14.

MR imaging of brainstem atrophy in progressive supranuclear palsy.

Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK.

J Neurol. 2008 Jan;255(1):37-44. Epub 2007 Dec 19.

PMID:
18080856
15.

Imaging correlates of pathology in corticobasal syndrome.

Whitwell JL, Jack CR Jr, Boeve BF, Parisi JE, Ahlskog JE, Drubach DA, Senjem ML, Knopman DS, Petersen RC, Dickson DW, Josephs KA.

Neurology. 2010 Nov 23;75(21):1879-87. doi: 10.1212/WNL.0b013e3181feb2e8.

16.

Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.

Kaasinen V, Kangassalo N, Gardberg M, Isotalo J, Karhu J, Parkkola R, Sonninen P.

Neurol Sci. 2015 Jul;36(7):1251-3. doi: 10.1007/s10072-015-2184-3. Epub 2015 Mar 25.

PMID:
25805708
17.

MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.

Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilotto G, Canesi M, De Gaspari D, Triulzi F, Pezzoli G.

AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):927-32.

18.

Study of the rostral midbrain atrophy in progressive supranuclear palsy.

Kato N, Arai K, Hattori T.

J Neurol Sci. 2003 Jun 15;210(1-2):57-60.

PMID:
12736089
19.

Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy.

Looi JC, Macfarlane MD, Walterfang M, Styner M, Velakoulis D, Lätt J, van Westen D, Nilsson C.

Psychiatry Res. 2011 Nov 30;194(2):163-75. doi: 10.1016/j.pscychresns.2011.07.013. Epub 2011 Sep 6.

20.

Morning glory sign: a particular MR finding in progressive supranuclear palsy.

Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T.

Magn Reson Med Sci. 2004 Dec 15;3(3):125-32.

Supplemental Content

Support Center